bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.01.21.700887

Structural Brain Indicators of Cognitive Performance in Middle and Late Adulthood: The Human Connectome Project in Aging/Aging Adult Brain Connectome Cohort

Abstract

IntroductionSignificant effort has been put towards mapping patterns of atrophy in the cerebral cortex that are related to pathological aging, including the characteristic patterns of neurodegeneration in Alzheimers disease (AD). In contrast, brain structural patterns that support preserved or even exceptional cognition throughout the adult age-span and especially in later life are much less known. It is possible that superior cognitive performance in late life is supported by a preservation of brain structures vulnerable to typical aging. Alternatively, elevated performance could be related to preservation of brain regions vulnerable to age-associated pathology. Examination of individuals that exhibit superior cognition throughout the adult lifespan may provide unique insights into neural mechanisms that support cognitive resilience in late life. MethodsWe examined cross-sectional associations between cortical brain structure and cognitive performance across three stages of adulthood: midlife (36-59), young-old (60-79), and older adults (80+) in typically aging individuals enrolled as part of the Human Connectome Project Lifespan-Aging (HCP-A)/Aging Adult Brain Connectome (AABC) studies. Participants were considered generally healthy and excluded for significant and/or atypical health conditions for their demographic category, including a clinical diagnosis of cognitive impairment or dementia. Domain-specific cognitive factor scores representing memory, fluid intelligence, and crystalized intelligence were sex-stratified and residualized relative to age, and participants were classified as high, middle, or low performers based on their unique performance relative to the study sample. ResultsIn the full sample, high performers demonstrated greater cortical thickness in regions of somatomotor, visual, and auditory cortices, as well as cortical areas in the frontal, parietal, and insular cortices (e.g., 5m, LIPv, MBelt). We also found associations between medial temporal and cingulate cortical thickness and cognitive performance, but only for select analyses. Group differences in cortical thickness were greatest when contrasting high and low performers for fluid intelligence compared to the other cognitive factors and were most prominent in the midlife participants compared to the other age strata. These group differences were primarily driven by reduced cortical thickness in the low performing individuals in the younger age bins relative to the typically performing sample. Effects were rather limited when contrasting high and low performers in the 80+ age group. The cortical areas of high statistical significance appeared to show a cross-sectional convergence effect, such that the differences in cortical thickness between high vs. low cognitive performance groups diminished with increasing age. Despite lower statistical power, effect sizes were greatest when contrasting individuals at the extremes of performance (e.g., top 10% vs. bottom 10% performers). These effects were robust to subsample replications using longitudinally defined cognitive classifications. DiscussionElevated cognitive performance was cross-sectionally associated with increased regional cortical thickness and effects were most prominent in mid-life compared to later ages. Notably, contrary to brain regions that may be expected to support such high-order cognitive performance, a significant portion of primary sensory, motor, and insular cortical areas exhibited group differences between the high- and low-performing groups in this relatively younger age group. Group differences were due to lower thickness in these regions in the low performing group relative to the typical performers. In contrast to the younger portion of the sample, regions typically considered vulnerable to Alzheimers disease (i.e., regions in the medial temporal lobe) were only infrequently implicated. These results suggest that specific patterns of cortical brain structural integrity including preserved thickness of primary motor and sensory cortical regions may be a necessary but not sufficient mechanism supporting superior cognitive abilities in earlier adulthood, while alternate neural mechanisms may support cognitive resilience later in life. These results must be interpreted with caution given the cross-sectional nature of this study. Cognitive capacity can only be estimated from a single timepoint, and several factors contribute to inter-individual variation that will not be accounted for in the models applied here. Longitudinal assessment of cognitive resilience in the HCP-A/AABC cohort will be performed in future work.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

HONG, Y., Michel, C., Gassner, G. M., Accorsi, C., Ances, B. M., Antonucci, L. M., Arnold, S. E., Babulal, G. M., Bookheimer, S. Y., Buckner, R. L., Cruchaga, C., Diaz-Santos, M., Elam, J. S., Van Essen, D., Ghahremani, D. G., Glasser, M. F., Harms, M. P., Juttukonda, M. R., Khay, A. M., Kufer, J. A., Lavretsky, H., Lenzini, P., Mair, R. W., Maki, P. M., Nichols, T. E., Oliver, A., Ratai, E. M., Vijayaraghavan, G., Welsh, R. C., Yacoub, E., Zhang, Y., Salat, D. H., Aging Adult Brain Connectome (AABC) Consortium,. 2026-01-22. Structural Brain Indicators of Cognitive Performance in Middle and Late Adulthood: The Human Connectome Project in Aging/Aging Adult Brain Connectome Cohort. https://doi.org/10.64898/2026.01.21.700887

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗